BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16635046)

  • 1. Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
    Raffa RB; Duong PV; Finney J; Garber DA; Lam LM; Mathew SS; Patel NN; Plaskett KC; Shah M; Jen Weng HF
    J Clin Pharm Ther; 2006 Apr; 31(2):129-38. PubMed ID: 16635046
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

  • 3. The (mis)classification of chemo-fog--methodological inconsistencies in the investigation of cognitive impairment after chemotherapy.
    Shilling V; Jenkins V; Trapala IS
    Breast Cancer Res Treat; 2006 Jan; 95(2):125-9. PubMed ID: 16261398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'.
    Raffa RB
    J Clin Pharm Ther; 2010 Feb; 35(1):1-9. PubMed ID: 20175809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.
    Raffa RB; Tallarida RJ
    J Clin Pharm Ther; 2010 Jun; 35(3):249-55. PubMed ID: 20831527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lost in the fog: understanding "chemo brain".
    Hafner DL
    Nursing; 2009 Aug; 39(8):42-5. PubMed ID: 19633502
    [No Abstract]   [Full Text] [Related]  

  • 7. Fighting the fog of "chemo brain." Chemotherapy may keep your cancer at bay but it also may cloud your mind.
    Duke Med Health News; 2009 Feb; 15(2):8-9. PubMed ID: 19353815
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
    Schagen SB; Das E; van Dam FS
    Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemo brain - a psychotropic drug phenomenon?
    Jackson GE
    Med Hypotheses; 2008; 70(3):572-7. PubMed ID: 17686588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-related change in cognitive function: a conceptual model.
    Hess LM; Insel KC
    Oncol Nurs Forum; 2007 Sep; 34(5):981-94. PubMed ID: 17878127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's "chemo brain"--and what can be done to counter it?
    Duke Med Health News; 2010 Jun; 16(6):8. PubMed ID: 20568654
    [No Abstract]   [Full Text] [Related]  

  • 13. The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition.
    Vardy J; Dhillon H
    Breast Cancer Res Treat; 2010 Aug; 123(1):35-7. PubMed ID: 20052534
    [No Abstract]   [Full Text] [Related]  

  • 14. A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog').
    Raffa RB
    J Clin Pharm Ther; 2011 Jun; 36(3):257-9. PubMed ID: 21545608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemobrain is real but may need new name.
    Hede K
    J Natl Cancer Inst; 2008 Feb; 100(3):162-3, 169. PubMed ID: 18230787
    [No Abstract]   [Full Text] [Related]  

  • 17. Acupuncture for chemotherapy-associated cognitive dysfunction: a hypothesis-generating literature review to inform clinical advice.
    Johnston MF; Yang C; Hui KK; Xiao B; Li XS; Rusiewicz A
    Integr Cancer Ther; 2007 Mar; 6(1):36-41. PubMed ID: 17351025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearing the air: a review of our current understanding of "chemo fog".
    O'Farrell E; MacKenzie J; Collins B
    Curr Oncol Rep; 2013 Jun; 15(3):260-9. PubMed ID: 23483375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phenomenon of chemo brain.
    Staat K; Segatore M
    Clin J Oncol Nurs; 2005 Dec; 9(6):713-21. PubMed ID: 16381547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
    Vardy J; Rourke S; Tannock IF
    J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.